Hematopoietic cell transplantation(HCT)confers a long-term disease-modifying therapy for transplant-permissive inherited metabolic diseases(IMDs). We examined the overall survival(OS)and engrafted survival(ES)of children with IMDs, who received first HCT at Royal Manchester Childrenʼs hospital from 1985 to 2016. | A decade of excellent transplant survival in children with inherited metabolic diseases: A report from a single metabolic transplant centre in Europe